Genetically altered bacteria help destroy cancerous tumors in mice

February 9, 2017 by Bob Yirka report
Salmonella forms a biofilm. Credit: CDC

(Medical Xpress)—A team of researchers affiliated with multiple institutions in Korea has found that genetically altering a type of bacteria and injecting it into cancerous mice resulted in the disappearance of tumors in more than half of test mice. In their paper published in the journal Science Translational Medicine, the researchers describe how they came upon the idea of altering a common type of bacteria to see if it might help fight cancer and the results of their tests.

The researchers report that they were working on two projects—developing a vaccine against a type of bacteria that was infecting shellfish and testing bacteria as a means for fighting cancer. They noticed that the bacteria that attacked shellfish produced a protein (FlaB) that caused a strong immune response. That led them to genetically modify the common salmonella bacteria so that it, too, would produce the protein. Salmonella, by its very nature, tends to seek out oxygen-poor tissue and kill it, which is why it has been studied as a fighter—tumors are naturally oxygen-poor environments. But while releasing salmonella into the bloodstreams of cancer-stricken mice has resulted in reduction of tumor size, the result was temporary—the tumors returned. This, the researchers believed, was due to the tumors not being completely eradicated. In this new effort, they added a second element to such attacks to help kill off some tumors completely.

The researchers found that their genetically modified made its way to several organs in the bodies of mice and also into tumors. The immune system then successfully eradicated the bacteria from the organs while simultaneously attacking the bacteria in the tumors and by extension the tumors themselves. This approach proved successful—11 out of 20 mice were tumor free after 12 days.

Engineered bacteria target tumors and activate the host immune system to eliminate cancer cells. Credit: Carla Schaffer / Zheng et al. / Science Translational Medicine

The researchers then embarked on another experiment—first transplanting metastasizing cancer cells into test mice and then injecting them with genetically altered and waiting to see what would happen. After 27 days, the researchers found that four out of eight mice had four or fewer tumors and some had none at all—meanwhile, all of the in a control group were found to have dozens of new tumors.

Explore further: Researchers use genetically modified circulating tumor cells to kill other tumors

More information: Jin Hai Zheng et al. Two-step enhanced cancer immunotherapy with engineeredsecreting heterologous flagellin, Science Translational Medicine (2017). DOI: 10.1126/scitranslmed.aak9537

Abstract
We report a method of cancer immunotherapy using an attenuated Salmonella typhimurium strain engineered to secrete Vibrio vulnificus flagellin B (FlaB) in tumor tissues. Engineered FlaB-secreting bacteria effectively suppressed tumor growth and metastasis in mouse models and prolonged survival. By using Toll-like receptor 5 (TLR5)–negative colon cancer cell lines, we provided evidence that the FlaB-mediated tumor suppression upon bacterial colonization is associated with TLR5-mediated host reactions in the tumor microenvironment. These therapeutic effects were completely abrogated in TLR4 and MyD88 knockout mice, and partly in TLR5 knockout mice, indicating that TLR4 signaling is a requisite for tumor suppression mediated by FlaB-secreting bacteria, whereas TLR5 signaling augmented tumor-suppressive host reactions. Tumor microenvironment colonization by engineered Salmonella appeared to induce the infiltration of abundant immune cells such as monocytes/macrophages and neutrophils via TLR4 signaling. Subsequent secretion of FlaB from colonizing Salmonella resulted in phenotypic and functional activation of intratumoral macrophages with M1 phenotypes and a reciprocal reduction in M2-like suppressive activities. Together, these findings provide evidence that nonvirulent tumor-targeting bacteria releasing multiple TLR ligands can be used as cancer immunotherapeutics.

Related Stories

Researchers use genetically modified circulating tumor cells to kill other tumors

February 9, 2016
(Medical Xpress)—An international team of medical researchers has found a way to use a kind of cancer cell as a cargo vessel of sorts to kill already existing tumors. In their paper published in Proceedings of the National ...

Silencing cancer cell communication may reduce the growth of tumors

January 30, 2017
In several types of cancer, elevated expression of the chemokine receptor CCR4 in tumors is associated with poor patient outcomes. Communication through CCR4 may be one mechanism that cancer cells use to create a pro-tumor ...

50-year-old bacteria could be alternative treatment option for cancer

October 27, 2016
According to the Centers for Disease Control, 48 million Americans contract foodborne diseases annually, with Salmonella being the leading cause of illness. Salmonella has a unique characteristic that allows the bacteria ...

Tumor-seeking salmonella treats brain tumors

January 11, 2017
Biomedical engineers at Duke University have recruited an unlikely ally in the fight against the deadliest form of brain cancer—a strain of salmonella that usually causes food poisoning.

Recommended for you

Outdoor light at night linked with increased breast cancer risk in women

August 17, 2017
Women who live in areas with higher levels of outdoor light at night may be at higher risk for breast cancer than those living in areas with lower levels, according to a large long-term study from Harvard T.H. Chan School ...

Scientists develop novel immunotherapy technology for prostate cancer

August 17, 2017
A study led by scientists at The Wistar Institute describes a novel immunotherapeutic strategy for the treatment of cancer based on the use of synthetic DNA to directly encode protective antibodies against a cancer specific ...

Scientists develop blood test that spots tumor-derived DNA in people with early-stage cancers

August 16, 2017
In a bid to detect cancers early and in a noninvasive way, scientists at the Johns Hopkins Kimmel Cancer Center report they have developed a test that spots tiny amounts of cancer-specific DNA in blood and have used it to ...

Toxic formaldehyde is produced inside our own cells, scientists discover

August 16, 2017
New research has revealed that some of the toxin formaldehyde in our bodies does not come from our environment - it is a by-product of an essential reaction inside our own cells. This could provide new targets for developing ...

Cell cycle-blocking drugs can shrink tumors by enlisting immune system in attack on cancer

August 16, 2017
In the brief time that drugs known as CDK4/6 inhibitors have been approved for the treatment of metastatic breast cancer, doctors have made a startling observation: in certain patients, the drugs—designed to halt cancer ...

Researchers find 'switch' that turns on immune cells' tumor-killing ability

August 16, 2017
Molecular biologists led by Leonid Pobezinsky and his wife and research collaborator Elena Pobezinskaya at the University of Massachusetts Amherst have published results that for the first time show how a microRNA molecule ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.